Debt to EBITDA ratio Analysis of Zynerba Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of ZYNE
Dec-22-0.0062Very Poor Debt to EBITDA | Dec-21-0.0056Very Poor Debt to EBITDA | Growth-9.42% |
Debt to EBITDA Analysis of Zynerba Pharmaceuticals Inc
| Debt to EBITDA Ratio of ZYNE has fallen by -9.42 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 0 was highest in Year Dec-18 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.0074 was lowest in Year Dec-19 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0062 is lower than Average Debt to EBITDA of -0.0043 in last five years. |
Other Debt to EBITDA Related Info of ZYNE that may interest you.
Zynerba Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ZYNE | 1.3 | 1.27 | 2.36 % | Drug Manufacturers-Specialty & Generic |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Mild Stability | |
FY - Historical Debt to EBITDA of Zynerba Pharmaceuticals Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.0062 | -0.0056 | -0.0021 | -0.0074 | 0 | 0 | 0 |
| Change | -9.42 % | -162.95 % | 71.11 % |
FY Chart of Debt to EBITDA of Zynerba Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)